Analysts have given Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) an average recommendation of “Hold.”
According to Bloomberg, the eight brokerages currently covering Ginkgo Bioworks Holdings Inc. (NYSE: DNA) have given the company’s stock an average rating of “Hold.” One …